MPO and obesity due to melanocortin 4 receptor deficiency: The present study aimed to determine the plasma ANGPTL6 and MPO levels in both obese and diabetic individuals to validate their role in these conditions and to assess any association between MPO levels and the markers of obesity, inflammation, and atherosclerosis.